Monovisc® is a viscosupplement that contains a gel-like substance manufactured from ultra-pure, non-avian hyaluronic acid that supplements the hyaluronic acid naturally found in the synovial fluid of a healthy knee.
A single, intra-articular injection of Monovisc® can provide osteoarthritis knee pain relief that’s felt as early as 2 weeks following the injection and that can last up to
6 months.
Over time, changes in the synovial fluid and degeneration of joint structures may lead to osteoarthritis knee pain.
Hyaluronic acid is a naturally occurring substance found in the synovial fluid of the knee joint. Viscosupplementation, or the injection of hyaluronic acid into the joint, is thought to lubricate the cartilage (much as oil lubricates an engine), thereby reducing pain for long-term relief.
When you have osteoarthritis, there may not be enough natural hyaluronic acid in the joint, and the quality of that hyaluronic acid may be poorer than normal.
Monovisc® delivers ultra-pure, well-tolerated hyaluronic acid directly into the knee joint to improve the lubricant properties of the synovial fluid and provide long-term osteoarthritis knee pain relief.
If oral painkillers and lifestyle changes such as exercising and losing weight are not providing you with adequate pain relief, Monovisc® may be a good option to relieve your osteoarthritis knee pain.
Access our private insurance coverage guide for reimbursement information on Monovisc®.
Cingal® and Orthovisc® are other viscosupplement options.
Cingal® is a single-injection osteoarthritis knee pain relief treatment that combines the fast* relief of a corticosteroid with the long-lasting† relief of a viscosupplement.
Orthovisc® is indicated for the symptomatic treatment of osteoarthritis of the knee. It is administered as three intra-articular injections over the course of three visits, each one week apart.
Use our clinic locator to find a specialist near you who can diagnose the cause of your knee pain and guide you through your treatment options.
*Significant reduction in pain measures seen at Week 1 vs. saline (ITT p=0.008).
†Pain relief up to 6 months.